JAMA Network Open (@JAMANetworkOpen) header
JAMA Network Open (@JAMANetworkOpen) profile picture

JAMA Network Open is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

Chicago, IL
Joined April 2017
Photo by JAMA Network Open (@JAMANetworkOpen)Photo by JAMA Network Open (@JAMANetworkOpen)Photo by JAMA Network Open (@JAMANetworkOpen)Photo by JAMA Network Open (@JAMANetworkOpen)Photo by JAMA Network Open (@JAMANetworkOpen)Photo by JAMA Network Open (@JAMANetworkOpen)Photo by JAMA Network Open (@JAMANetworkOpen)Photo by JAMA Network Open (@JAMANetworkOpen)Photo by JAMA Network Open (@JAMANetworkOpen)Photo by JAMA Network Open (@JAMANetworkOpen)
#ScientificSessions26 from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease. ja.ma/4j4RAWI
3
6
426
📊 Research Summary: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy. ja.ma/3WxgIwG #ScientificSessions26
1
133
📣 Stay connected with the JAMA Network at #ScientificSessions26! Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4eY16Zp
112
From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone. ja.ma/3WzzW4M #ScientificSessions26
2
1
2
516
📣 Stay connected with the JAMA Network at #ScientificSessions26! Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4BUb6wQ
209
💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients. ja.ma/4ep2QLb #ScientificSessions26
328
📊 Research Summary from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease. ja.ma/4kEJh59 #ScientificSessions26
313
Presented at #ScientificSessions26 from @JAMA_current: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy. ja.ma/4iu7iuq
1
2
405
#ScientificSessions26 from @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention. ja.ma/4zDOuis
1
296
📣 Stay connected with the JAMA Network at #ScientificSessions26! Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4zISsq3
122
💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients. ja.ma/4iA71F6 #ScientificSessions26
1
1
1
452
📊 Research Summary from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease. ja.ma/4iLmgLx #ScientificSessions26
1
1
2
432
Presented at #ScientificSessions26 from @JAMA_current: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy. ja.ma/4sUvUQI
345
#ScientificSessions26 from @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention. ja.ma/4iqGuLE
1
313
📣 Stay connected with the JAMA Network at #ScientificSessions26! Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4kFbYit
122
From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone. ja.ma/4zzhCHH #ScientificSessions26
1
3
466
📣 Stay connected with the JAMA Network at #ScientificSessions26! Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4sMCclj
125
🎉 Exhibits at #AHA26 are open. Find @JAMA_current, @JAMACardio, @JAMAInternalMed, and @JAMANetworkOpen at booth 537. Get recent articles, find out when you can meet our editors, and ask us about publishing opportunities and submitting your work. ja.ma/4k33TEc
319
In 2027, JAMA will convene leaders across #medicine, research, #technology, industry, and #policy to address how #AI will reshape health care and biomedical science. Learn more: ja.ma/4BHTvYI #HealthAfterAI #JAMASummit
1
422